Inadequate testing thwarts efforts to measure Zika's impact


  • World
  • Friday, 05 Feb 2016

RIO DE JANEIRO (Reuters) - One major hurdle is thwarting efforts to measure the extent of the Zika epidemic and its suspected links to thousands of birth defects in Brazil: accurate diagnosis of a virus that still confounds blood tests.

Genetic tests and clinical symptoms have enabled scientists to partially track Zika, and Brazil guesses up to 1.5 million people have been infected in the country.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

13 dead in central Senegal road accident
Indigenous people protest Brazil not protecting ancestral lands
Canada launches U.S. dollar global bond to bolster foreign reserves
Algeria hosts 23rd "Chinese Bridge" language competition for university students
Trump's three US Supreme Court appointees thrash out immunity claim
Alphabet reports revenues, net income jump in first quarter
Weekly storage of natural gas in U.S. increases: EIA
Intel reports revenue increase in first quarter
Microsoft reports Q3 results with net income, revenue increases
Finland's finance ministry downgrades growth forecast for 2024

Others Also Read